Statin Market: Global Industry Analysis and Forecast (2023-2029)

Statin Market was valued US$ 14.95 Bn in 2022 and is expected to reach US$ 18.39 Bn by 2029, at a CAGR of 3% during a forecast period. Statins are used for prevention and treatment for atherosclerosis, which causes chest pain, heart attacks, and strokes. It is mostly prescribed to lower down the low density lipoprotein cholesterol in the body and helps to reduce mortality in high risk patients.Statin MarketTo know about the Research Methodology :- Request Free Sample Report

Statin Market Dynamics:

An increase in prevalence of cholesterol due to changing lifestyle are expected to increase the demand for statins across the globe. Sedentary lifestyle across the developed regions is one of the key drivers of the global market. The bad cholesterol is difficult to manage by diet and exercise, the statins are highly recommended to treat the condition. In addition, Cholesterol awareness campaigns and technologically advanced health care facilities are increasing the demand for statins. The rapid pace of urbanisation is leading to cholesterol-related disorders and ensuring sustained demand for statins. Cholesterol consciousness and technologically forward health administration amenities are some of the prominent factors behind the market growth. Despite the presence of the prominent driving factors, the requirement for adequate remedy options serves is expected to limit the global station market. The cultural and commercial agents and Side effects of statins are also expected to hamper the growth of the statin business.

Statin Market Segment Analysis:

In the global statin market, there are many different statin molecules like simvastatin, pravastatin, lovastatin and atorvastatin are present. The Simvastatin, lovastatin and pravastatin together have annual sales of more than $10 Bn globally. Among these, Lovastatin is already off patent across the globe and simvastatin and pravastatin are off patent in Europe.Statin MarketHigh low-density lipoprotein cholesterol is one of the modifiable risk factors for atherosclerotic cardiovascular disease. An increase in the number of patients, who are suffering from cardiovascular diseases are expected to increase the demand for statins across the globe. In the U.S., One person dies every 36 seconds from cardiovascular disease. It statins are widely used to reduce adverse cardiovascular outcomes. Despite the older individuals have the highest absolute risk for atherosclerotic cardiovascular disease, the US guidelines for blood pressure and cholesterol have recommended lower-intensity treatment strategies that are expected to drive the market growth. The Hospitals segment is expected to hold the dominant position in the global market. The dominant position in the market is attributed to the increased requirement for treatment of cardiovascular disorders and inflammatory disorders treatments. The healthcare providers are focusing on the enhancement of the patient admission capacities at hospitals, number of medical professionals and availability of the drugs for reduction of the cholesterol.

Statin Market Regional Analysis:

North America region held the dominant position in 2022 and is projected to continue its dominance during the forecast period. The market growth attribute to the presence of the number of cardiovascular disorders affected people and prominent healthcare service providers. An increase in occurrence of obesity, cardiovascular diseases and diabetes among old populations are expected to drive the demand for effective treatment of high cholesterol. In America, more than 70% American adults are suffering from LDL cholesterol. The American College of Cardiology and the American Heart Association have announced the guidelines that people with 7.5% or higher risk for heart attack have to be prescribed statins, which is expected to double statin usage in the US and Canada. The statins market has proved to be a lucrative and profitable market for the key players in the region. Consumption of statins is high among geriatrics population that is expected to boost the market growth in the near future.

Statin Market Competitive Analysis:

Some of the prominent key players like Abbott, AstraZeneca and Aurobindo Pharma are expanding their market presence across the globe by establishing strong distribution networks, mainly in developing countries. Furthermore, Indian pharmaceutical companies are also exciting to get a foothold in the global statins market. For instance, Big Indian pharmaceutical companies like Ranbaxy Laboratories and Lupin Laboratories are concentrating to form the their footprint in the statins market. The Indian key players are expect to take benefits by marketing statin generics. The objective of the report is to present a comprehensive analysis of the global market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding global market dynamics, structure by analyzing the market segments and projects the global market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.

Scope of the Statin Market: Inquire before buying

Statin Market
Base Year 2022 Forecast Period 2023-2029
Historical Data CAGR Market Size in 2022 Market Size in 2029
2018 to 2022 3% US$ 14.95 Bn US$ 18.39 Bn
Segments Covered
by Drug Class Astrovastatin Fluvastatin Lovastatin Pravastatin Simvastatin Others by Therapeutic Treatment Cardiovascular disorders Obesity Inflammatory disorders Others by End User Hospitals Clinics
Regions Covered
North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America

Statin Market Key players are:

1. Abbott 2. AstraZeneca 3. Aurobindo Pharma 4. Biocon 5. GlaxoSmithKline 6. Merck & Co. 7. Novartis 8. Pfizer 9. Bayer 10.Amgen Inc. 11.Concord Biotech Frequently Asked Questions: 1. Which region has the largest share in Global Statin Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Statin Market? Ans: The Global Statin Market is growing at a CAGR of 3% during forecasting period 2023-2029. 3. What segments are covered in Global Statin market? Ans: Statin Market is segmented into drug class, therapeutic treatment, end user and region. 4. Who are the key players in Global Statin market? Ans: The important key players in the Statin Market are – Abbott, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, Bayer, Amgen Inc., Concord Biotech 5. What is the study period of this market? Ans: The Global Statin Market is studied from 2022 to 2029.
1. Statin Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Statin Market: Dynamics 2.1. Statin Market Trends by Region 2.1.1. North America Statin Market Trends 2.1.2. Europe Statin Market Trends 2.1.3. Asia Pacific Statin Market Trends 2.1.4. Middle East and Africa Statin Market Trends 2.1.5. South America Statin Market Trends 2.2. Statin Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Statin Market Drivers 2.2.1.2. North America Statin Market Restraints 2.2.1.3. North America Statin Market Opportunities 2.2.1.4. North America Statin Market Challenges 2.2.2. Europe 2.2.2.1. Europe Statin Market Drivers 2.2.2.2. Europe Statin Market Restraints 2.2.2.3. Europe Statin Market Opportunities 2.2.2.4. Europe Statin Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Statin Market Drivers 2.2.3.2. Asia Pacific Statin Market Restraints 2.2.3.3. Asia Pacific Statin Market Opportunities 2.2.3.4. Asia Pacific Statin Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Statin Market Drivers 2.2.4.2. Middle East and Africa Statin Market Restraints 2.2.4.3. Middle East and Africa Statin Market Opportunities 2.2.4.4. Middle East and Africa Statin Market Challenges 2.2.5. South America 2.2.5.1. South America Statin Market Drivers 2.2.5.2. South America Statin Market Restraints 2.2.5.3. South America Statin Market Opportunities 2.2.5.4. South America Statin Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Statin Industry 2.8. Analysis of Government Schemes and Initiatives For Statin Industry 2.9. Statin Market Trade Analysis 2.10. The Global Pandemic Impact on Statin Market 3. Statin Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Statin Market Size and Forecast, by Drug Class (2022-2029) 3.1.1. Astrovastatin 3.1.2. Fluvastatin 3.1.3. Lovastatin 3.1.4. Pravastatin 3.1.5. Simvastatin 3.1.6. Others 3.2. Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 3.2.1. Cardiovascular disorders 3.2.2. Obesity 3.2.3. Inflammatory disorders 3.2.4. Others 3.3. Statin Market Size and Forecast, by End User (2022-2029) 3.3.1. Hospitals 3.3.2. Clinics 3.4. Statin Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Statin Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Statin Market Size and Forecast, by Drug Class (2022-2029) 4.1.1. Astrovastatin 4.1.2. Fluvastatin 4.1.3. Lovastatin 4.1.4. Pravastatin 4.1.5. Simvastatin 4.1.6. Others 4.2. North America Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 4.2.1. Cardiovascular disorders 4.2.2. Obesity 4.2.3. Inflammatory disorders 4.2.4. Others 4.3. North America Statin Market Size and Forecast, by End User (2022-2029) 4.3.1. Hospitals 4.3.2. Clinics 4.4. North America Statin Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Statin Market Size and Forecast, by Drug Class (2022-2029) 4.4.1.1.1. Astrovastatin 4.4.1.1.2. Fluvastatin 4.4.1.1.3. Lovastatin 4.4.1.1.4. Pravastatin 4.4.1.1.5. Simvastatin 4.4.1.1.6. Others 4.4.1.2. United States Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 4.4.1.2.1. Cardiovascular disorders 4.4.1.2.2. Obesity 4.4.1.2.3. Inflammatory disorders 4.4.1.2.4. Others 4.4.1.3. United States Statin Market Size and Forecast, by End User (2022-2029) 4.4.1.3.1. Hospitals 4.4.1.3.2. Clinics 4.4.2. Canada 4.4.2.1. Canada Statin Market Size and Forecast, by Drug Class (2022-2029) 4.4.2.1.1. Astrovastatin 4.4.2.1.2. Fluvastatin 4.4.2.1.3. Lovastatin 4.4.2.1.4. Pravastatin 4.4.2.1.5. Simvastatin 4.4.2.1.6. Others 4.4.2.2. Canada Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 4.4.2.2.1. Cardiovascular disorders 4.4.2.2.2. Obesity 4.4.2.2.3. Inflammatory disorders 4.4.2.2.4. Others 4.4.2.3. Canada Statin Market Size and Forecast, by End User (2022-2029) 4.4.2.3.1. Hospitals 4.4.2.3.2. Clinics 4.4.3. Mexico 4.4.3.1. Mexico Statin Market Size and Forecast, by Drug Class (2022-2029) 4.4.3.1.1. Astrovastatin 4.4.3.1.2. Fluvastatin 4.4.3.1.3. Lovastatin 4.4.3.1.4. Pravastatin 4.4.3.1.5. Simvastatin 4.4.3.1.6. Others 4.4.3.2. Mexico Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 4.4.3.2.1. Cardiovascular disorders 4.4.3.2.2. Obesity 4.4.3.2.3. Inflammatory disorders 4.4.3.2.4. Others 4.4.3.3. Mexico Statin Market Size and Forecast, by End User (2022-2029) 4.4.3.3.1. Hospitals 4.4.3.3.2. Clinics 5. Europe Statin Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Statin Market Size and Forecast, by Drug Class (2022-2029) 5.2. Europe Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.3. Europe Statin Market Size and Forecast, by End User (2022-2029) 5.4. Europe Statin Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.1.2. United Kingdom Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.1.3. United Kingdom Statin Market Size and Forecast, by End User(2022-2029) 5.4.2. France 5.4.2.1. France Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.2.2. France Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.2.3. France Statin Market Size and Forecast, by End User(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.3.2. Germany Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.3.3. Germany Statin Market Size and Forecast, by End User (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.4.2. Italy Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.4.3. Italy Statin Market Size and Forecast, by End User(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.5.2. Spain Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.5.3. Spain Statin Market Size and Forecast, by End User (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.6.2. Sweden Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.6.3. Sweden Statin Market Size and Forecast, by End User (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.7.2. Austria Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.7.3. Austria Statin Market Size and Forecast, by End User (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Statin Market Size and Forecast, by Drug Class (2022-2029) 5.4.8.2. Rest of Europe Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 5.4.8.3. Rest of Europe Statin Market Size and Forecast, by End User (2022-2029) 6. Asia Pacific Statin Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Statin Market Size and Forecast, by Drug Class (2022-2029) 6.2. Asia Pacific Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.3. Asia Pacific Statin Market Size and Forecast, by End User (2022-2029) 6.4. Asia Pacific Statin Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.1.2. China Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.1.3. China Statin Market Size and Forecast, by End User (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.2.2. S Korea Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.2.3. S Korea Statin Market Size and Forecast, by End User (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.3.2. Japan Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.3.3. Japan Statin Market Size and Forecast, by End User (2022-2029) 6.4.4. India 6.4.4.1. India Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.4.2. India Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.4.3. India Statin Market Size and Forecast, by End User (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.5.2. Australia Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.5.3. Australia Statin Market Size and Forecast, by End User (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.6.2. Indonesia Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.6.3. Indonesia Statin Market Size and Forecast, by End User (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.7.2. Malaysia Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.7.3. Malaysia Statin Market Size and Forecast, by End User (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.8.2. Vietnam Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.8.3. Vietnam Statin Market Size and Forecast, by End User(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.9.2. Taiwan Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.9.3. Taiwan Statin Market Size and Forecast, by End User (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Statin Market Size and Forecast, by Drug Class (2022-2029) 6.4.10.2. Rest of Asia Pacific Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 6.4.10.3. Rest of Asia Pacific Statin Market Size and Forecast, by End User (2022-2029) 7. Middle East and Africa Statin Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Statin Market Size and Forecast, by Drug Class (2022-2029) 7.2. Middle East and Africa Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 7.3. Middle East and Africa Statin Market Size and Forecast, by End User (2022-2029) 7.4. Middle East and Africa Statin Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Statin Market Size and Forecast, by Drug Class (2022-2029) 7.4.1.2. South Africa Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 7.4.1.3. South Africa Statin Market Size and Forecast, by End User (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Statin Market Size and Forecast, by Drug Class (2022-2029) 7.4.2.2. GCC Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 7.4.2.3. GCC Statin Market Size and Forecast, by End User (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Statin Market Size and Forecast, by Drug Class (2022-2029) 7.4.3.2. Nigeria Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 7.4.3.3. Nigeria Statin Market Size and Forecast, by End User (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Statin Market Size and Forecast, by Drug Class (2022-2029) 7.4.4.2. Rest of ME&A Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 7.4.4.3. Rest of ME&A Statin Market Size and Forecast, by End User (2022-2029) 8. South America Statin Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Statin Market Size and Forecast, by Drug Class (2022-2029) 8.2. South America Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 8.3. South America Statin Market Size and Forecast, by End User(2022-2029) 8.4. South America Statin Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Statin Market Size and Forecast, by Drug Class (2022-2029) 8.4.1.2. Brazil Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 8.4.1.3. Brazil Statin Market Size and Forecast, by End User (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Statin Market Size and Forecast, by Drug Class (2022-2029) 8.4.2.2. Argentina Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 8.4.2.3. Argentina Statin Market Size and Forecast, by End User (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Statin Market Size and Forecast, by Drug Class (2022-2029) 8.4.3.2. Rest Of South America Statin Market Size and Forecast, by Therapeutic Treatment (2022-2029) 8.4.3.3. Rest Of South America Statin Market Size and Forecast, by End User (2022-2029) 9. Global Statin Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Statin Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Abbott 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. AstraZeneca 10.3. Aurobindo Pharma 10.4. Biocon 10.5. GlaxoSmithKline 10.6. Merck & Co. 10.7. Novartis 10.8. Pfizer 10.9. Bayer 10.10. Amgen Inc. 10.11. Concord Biotech 11. Key Findings 12. Industry Recommendations 13. Statin Market: Research Methodology 14. Terms and Glossary

About This Report

Report ID 77560
Category Healthcare
Published Date Oct 2023
Updated Date
  • INQUIRE BEFORE BUYING